LSE:AZN (AstraZeneca PLC)
About AZN
AstraZeneca is a biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three main therapy areas - Respiratory, Inflammation and Autoimmunity (RIA), Cardiovascular and Metabolic Disease (CVMD) and Oncology – as well as in Infection and Neuroscience.
AstraZeneca PLC (LSE: AZN) Latest News
Investing Articles
£10,000 invested in the FTSE 100 at the start of the year is now worth…
Investing Articles
Down 28% in 8 months, is AstraZeneca’s share price too cheap for me to pass up right now?
Investing Articles
Just opened a Stocks and Shares ISA? Here are 10 stocks to consider buying, according to AI
Investing Articles
I asked ChatGPT where the FTSE 100 will be in 6 months: here’s what it said…
Investing Articles
These FTSE shares may offer some safety as Trump slaps tariffs on trading partners
Investing Articles
3 top FTSE 100 shares to consider for a new ISA
Investing Articles
A £10,000 investment in AstraZeneca shares last Christmas is now worth…
Investing Articles
Prediction: 12 months from now, AstraZeneca’s share price could be…
Investing Articles
£10,000 invested in AstraZeneca shares 1 year ago is now worth…
Investing Articles
I asked ChatGPT to name 5 UK stocks for a perfectly balanced ISA – here’s what it picked!
Investing Articles
Down 13% from its year high at £116.50 now, AstraZeneca’s share price looks cheap to me anywhere under £219.81